Nilüfer Göknar

455 total citations
31 papers, 286 citations indexed

About

Nilüfer Göknar is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Nilüfer Göknar has authored 31 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Nephrology. Recurrent topics in Nilüfer Göknar's work include Renal Diseases and Glomerulopathies (5 papers), Complement system in diseases (4 papers) and Pelvic floor disorders treatments (3 papers). Nilüfer Göknar is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Complement system in diseases (4 papers) and Pelvic floor disorders treatments (3 papers). Nilüfer Göknar collaborates with scholars based in Türkiye, United States and India. Nilüfer Göknar's co-authors include Aysel Vehapoğlu, Emel Torun, Ayşegül Doğan Demir, Faruk Öktem, Beyhan Tüysüz, İlker Tolga Özgen, Yaşar Cesur, Serdar Türkmen, Ömer Faruk Özer and Zeynep Yürük Yıldırım and has published in prestigious journals such as SHILAP Revista de lepidopterología, Urology and Pediatric Nephrology.

In The Last Decade

Nilüfer Göknar

28 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nilüfer Göknar Türkiye 10 67 57 55 46 41 31 286
Zvonimir Puretić Croatia 9 116 1.7× 42 0.7× 82 1.5× 59 1.3× 36 0.9× 22 379
Elen Almeida Romão Brazil 10 121 1.8× 47 0.8× 26 0.5× 23 0.5× 44 1.1× 38 325
Anna E. Denoble United States 6 91 1.4× 33 0.6× 47 0.9× 54 1.2× 57 1.4× 36 422
Ayşe Ağbaş Türkiye 10 66 1.0× 36 0.6× 25 0.5× 19 0.4× 18 0.4× 31 233
Annick Massart Belgium 14 147 2.2× 72 1.3× 56 1.0× 60 1.3× 69 1.7× 34 490
Narendra Kumar Bagri India 10 21 0.3× 41 0.7× 23 0.4× 23 0.5× 47 1.1× 54 296
Lama Elbahlawan United States 9 36 0.5× 32 0.6× 34 0.6× 18 0.4× 106 2.6× 29 256
Hong Si Nga Brazil 10 93 1.4× 14 0.2× 38 0.7× 60 1.3× 45 1.1× 23 253
Mohammad Hossein Fallahzadeh Iran 11 85 1.3× 94 1.6× 10 0.2× 31 0.7× 44 1.1× 48 328
Franck Martinez France 9 144 2.1× 53 0.9× 24 0.4× 27 0.6× 123 3.0× 11 394

Countries citing papers authored by Nilüfer Göknar

Since Specialization
Citations

This map shows the geographic impact of Nilüfer Göknar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilüfer Göknar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilüfer Göknar more than expected).

Fields of papers citing papers by Nilüfer Göknar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nilüfer Göknar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilüfer Göknar. The network helps show where Nilüfer Göknar may publish in the future.

Co-authorship network of co-authors of Nilüfer Göknar

This figure shows the co-authorship network connecting the top 25 collaborators of Nilüfer Göknar. A scholar is included among the top collaborators of Nilüfer Göknar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nilüfer Göknar. Nilüfer Göknar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Göknar, Nilüfer, et al.. (2024). Is Nutcracker Syndrome Innocent?. SHILAP Revista de lepidopterología. 24(1). 11–14.
2.
Göknar, Nilüfer, et al.. (2023). Meningococcemia in a vaccinated child receiving eculizumab and review of the literature. The Turkish Journal of Pediatrics. 65(1). 129–134.
3.
Saygılı, Seha, Bora Gülhan, Nur Canpolat, et al.. (2022). A broad clinical spectrum of PLCε1-related kidney disease and intrafamilial variability. Pediatric Nephrology. 37(8). 1855–1866. 2 indexed citations
4.
Göknar, Nilüfer, et al.. (2022). A case of chronic kidney disease with pulmonary hypertension, hyperuricemia, immunodeficiency and other extrarenal findings: Questions. Pediatric Nephrology. 37(11). 2615–2616. 1 indexed citations
5.
Göknar, Nilüfer, et al.. (2022). Long-term Results in Children with Henoch-Schönlein Nephritis. SHILAP Revista de lepidopterología. 37(2). 159–164. 2 indexed citations
6.
Taşdemir, Mehmet, Nur Canpolat, Nurdan Yıldız, et al.. (2021). Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(4). 1781–1790. 3 indexed citations
7.
8.
Göknar, Nilüfer, et al.. (2021). Hepatocyte Nuclear Factor 1 Beta Mutation-associated Newborn Onset of Glomerulocystic Kidney Disease: A Case Presentation. SHILAP Revista de lepidopterología. 36(4). 352–355. 2 indexed citations
9.
Canpolat, Nur, Zeynep Yürük Yıldırım, Nurdan Yıldız, et al.. (2021). COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation. European Journal of Pediatrics. 181(1). 117–123. 15 indexed citations
10.
Göknar, Nilüfer. (2020). Güncel kılavuzlar eşliğinde çocukluk çağı hipertansiyonu. Türk Pediatri Arşivi. 55(1). 11–22. 7 indexed citations
11.
Ağbaş, Ayşe, Nilüfer Göknar, Nurver Akıncı, et al.. (2018). Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab. Pediatric Nephrology. 33(12). 2371–2381. 18 indexed citations
12.
Göknar, Nilüfer, et al.. (2018). Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab. Pediatric Nephrology. 33(6). 1093–1096. 8 indexed citations
13.
Vehapoğlu, Aysel, et al.. (2017). Risk factors for childhood obesity: Do the birth weight, type of delivery, and mother’s overweight have an implication on current weight status?. World Journal of Pediatrics. 13(5). 457–464. 21 indexed citations
14.
Vehapoğlu, Aysel, Serdar Türkmen, Nilüfer Göknar, & Ömer Faruk Özer. (2016). Reduced antioxidant capacity and increased subclinical inflammation markers in prepubescent obese children and their relationship with nutritional markers and metabolic parameters. Redox Report. 21(6). 271–280. 25 indexed citations
15.
Vehapoğlu, Aysel, et al.. (2016). Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin. The Turkish Journal of Pediatrics. 58(2). 216–219. 11 indexed citations
16.
Göknar, Nilüfer, Faruk Öktem, Ayşegül Doğan Demir, Aysel Vehapoğlu, & Mesrur Selçuk Sılay. (2016). Comparison of Two Validated Voiding Questionnaires and Clinical Impression in Children With Lower Urinary Tract Symptoms: ICIQ-CLUTS Versus Akbal Survey. Urology. 94. 214–217. 6 indexed citations
17.
Göknar, Nilüfer, et al.. (2015). Kawasaki Hastalığı Şok Sendromu. Çocuk Dergisi / Journal of Child. 15(2). 86–88. 1 indexed citations
18.
Göknar, Nilüfer, Erkan Çakır, Fatma Betül Çakır, et al.. (2015). A Difficult Case of Hodgkin Lymphoma with Differential Diagnosis of Tuberculosis and Sarcoidosis. Hematology Reports. 7(2). 5644–5644. 5 indexed citations
19.
Göknar, Nilüfer, et al.. (2014). Is oxidative stress related to childhood urolithiasis?. Pediatric Nephrology. 29(8). 1381–1386. 10 indexed citations
20.
Sılay, Mesrur Selçuk, Nilüfer Göknar, Abdülkadir Tepeler, et al.. (2013). Who Should We Trust in Screening for Lower Urinary Tract Dysfunction in Children: The Parents or the Child?. Urology. 82(2). 437–441. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zvonimir Puretić Breakdown of academic impact, for papers by Elen Almeida Romão Breakdown of academic impact, for papers by Anna E. Denoble Breakdown of academic impact, for papers by Ayşe Ağbaş Breakdown of academic impact, for papers by Annick Massart Breakdown of academic impact, for papers by Narendra Kumar Bagri Breakdown of academic impact, for papers by Lama Elbahlawan Breakdown of academic impact, for papers by Hong Si Nga Breakdown of academic impact, for papers by Mohammad Hossein Fallahzadeh Breakdown of academic impact, for papers by Franck Martinez
Rankless by CCL
2026